Inflazome

12 results

Prof Luke O’Neill: Music is the one thing that held me together during the pandemic. Photograph: Nick Bradshaw

Without overstating it, I would be in bits by now without music. It is the one thing that held me together during the pandemic, in some ways. It’s so (...)

Ryanair flew into the pandemic with a relatively strong balance sheet. Photograph: Eric Luke

How do you weigh up the annus covidius horribilis of 2020 in words that don’t have to be asterisked? It was a year when a virus inflicted a brutal en(...)

Chief executive of Life Scientific, and overall EY Entrepreneur Of The Year 2020 winner,   Nicola Mitchell with her husband Enda O’Coineen. Photograph: Naoise Culhane

Nicola Mitchell, founder and chief executive of Irish agrochemicals company Life Scientific, has scooped this year’s overall EY Entrepreneur of the Ye(...)

Matt Cooper, co-founder and chief executive of Inflazome

Matt Cooper, co-founder and chief executive of Irish biotech company Inflazome, has won top prize in the emerging category at the EY Entrepreneur of t(...)

Aidan King, Dr Manus Rogan and Dr Ena Prosser of Fountain Healthcare Partners.  Photograph: Nick Bradshaw

Irish life sciences investor Fountain Healthcare Partners has closed its third fund, having raised €125 million. It brings to just over €300 million t(...)

A Dublin company chasing a cure for one of the most common forms of leukaemia has raised €30 million.

Irish life sciences venture capital group Fountain Healthcare Partners has led a €30 million fundraising for a new company hunting for treatment for o(...)

Prof Matt Cooper: ‘If you want to get a drug to patients with these really sad diseases that affect us all eventually, or our families, the more shots on goal there are, whether it be Inflazome or someone else.’

It all began with a chance meeting. Trinity immunologist Professor Luke O’Neill was attending a medical conference in Australia when he bumped into Ma(...)

Inflazome chairman Dr Manus Rogan with co-founders Dr Matt Cooper and and Prof Luke O’Neill, and Dr Jeremy Skillington, vice-president of business development. Photograph: Nick Bradshaw

Covid-19 might be making 2020 an annus horribilis for most businesses, but it has been a year to remember for Fountain Healthcare Partners. The ventu(...)

Inflazome chairman Dr Manus Rogan, co-founders Dr Matt Cooper and Prof Luke O’Neill, and Dr Jeremy Skillington, vice-president, business development, photographed in 2016. Photograph: Nick Bradshaw

Swiss drug giant Roche has paid €380 million upfront for a four-year-old Irish biotech company working on treatments to meet clinically unmet needs in(...)

 Immunnologist Prof Luke O’Neill, who is a co-founder and chief scientific officer at Inflamazone. Photograph: Nick Bradshaw

Irish specialty drug developer Inflazome has secured orphan drug designation for Inzomelid, a therapy that it is developing. Inflazome specialises i(...)

  • 1
  • 2
  • Next
  • Last »